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Background: Epidemiological transition in high HIV-burden settings is resulting in a rise in HIV/NCD multimorbidity.
The majority of NCD risk behaviours start during adolescence, making this an important target group for NCD
prevention and multimorbidity prevention in adolescents with a chronic condition such as HIV. However, there is
data paucity on NCD risk and prevention in adolescents with HIV in high HIV-burden settings. The aim of this study
was to investigate the extent to which NCD comorbidity (prevention, diagnosis, and management) is incorporated
within existing adolescent HIV primary healthcare services in Cape Town, South Africa.
Methods: We reviewed medical records of 491 adolescents and youth living with HIV (AYLHIV) aged 10–24 years
across nine primary care facilities in Cape Town from November 2018–March 2019. Folders were systematically
sampled from a master list of all AYLHIV per facility and information on HIV management and care, NCDs, NCD risk
and NCD-related health promotion extracted.
Results: The median age was 20 years (IQR: 14–23); median age at ART initiation 18 years (IQR: 6–21) and median
duration on ART 3 years (IQR: 1.1–8.9). Fifty five percent of participants had a documented comorbidity, of which
11% had an NCD diagnosis with chronic respiratory diseases (60%) and mental disorders (37%) most common. Of
those with documented anthropometrics (62%), 48% were overweight or obese. Fifty nine percent of participants
had a documented blood pressure, of which 27% were abnormal. Twenty-six percent had a documented health
promoting intervention, 42% of which were NCD-related; ranging from alcohol or substance abuse (13%); smoking
(9%); healthy weight or diet (9%) and mental health counselling (10%).
Conclusions: Our study demonstrates limited NCD screening and health promotion in AYLHIV accessing healthcare
services. Where documented, our data demonstrates existing NCD comorbidity and NCD risk factors highlighting a
missed opportunity for multimorbidity prevention through NCD screening and health promotion. Addressing this
missed opportunity requires an integrated health system and intersectoral action on upstream NCD determinants
to turn the tide on the rising NCD and multimorbidity epidemic.
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Emerging NCD epidemic in low and middle-income
countries
Non-communicable diseases (NCDs) are responsible for
more than half of the global burden of disease [1] with
71% of global deaths in 2016 due to NCDs [2]. The bur-
den of NCDs is increasing most rapidly in low- and
middle-income countries (LMIC) with NCDs projected
to account for nearly half of the burden of disease in
low-income countries by 2030 and a four-fold higher
probability of NCD-related premature deaths compared
to high-income countries [2]. This trend is driven by
rapid unplanned urbanization, globalization of unhealthy
lifestyles such as tobacco use, physical inactivity, un-
healthy diet and harmful use of alcohol [3] and popula-
tion ageing [4, 5], resulting in a protracted
epidemiological transition [6] with an emerging epi-
demic of obesity, diabetes and other NCDs alongside
persisting infectious disease epidemics [7].
Of note, NCDs are affecting younger populations, and
are associated with worse health and economic out-
comes in low- and middle-income countries compared
to high-income countries [8]. The estimated overall cost
of diabetes in sub-Saharan Africa was US$19·45 billion
or 1·2% of cumulative gross domestic product in 2015
[9] with health systems unable to provide adequate man-
agement for diabetes and its associated risk factors and
sequelae [9]. This growing cost of NCDs is of particular
concern as LMICs are grappling with higher levels of
NCD at earlier stages of economic development, with
fewer resources, and with less time to respond effectively
[10]. This highlights the importance of a focus on pre-
vention of NCDs through early identification of modifi-
able risk factors at the primary care level across the life-
course as the most feasible and cost- effective approach
to maintaining population health [11].
NCD prevention in adolescents
Adolescence, a period of transition from childhood to
adulthood, is defined as the period between the ages of
10–19 years [12], with some definitions extending this
life stage to 24 years [13]. It is a period that comes with
unique challenges as adolescents strive to develop auton-
omy and self-identity through exploration and risk-
taking [14–16], with a significant part of adolescence
lying in its power to translate childhood experiences into
competencies and statuses that facilitate the transition to
adulthood [16].
Adolescents and youth aged 10–24 years make up over
25% of the global population, and their numbers are set
to rise to two billion by 2032 [17]. Africa has the youn-
gest population in the world, with more than one-third
of the total population of sub-Saharan African aged 10
to 24 years [18]. Although adolescents are generallyhealthy, up to 70% of premature adult deaths reflect be-
haviours started or reinforced during adolescence [19].
Worldwide, over 10% of young people smoke [20], 81%
of adolescents have insufficient physical activity; and
11.7% of adolescents partake in heavy episodic drinking
[3, 21]. This is further shaped by the social and commer-
cial determinants of health which influence health-
related behaviours. Reinforcing healthier behaviours and
protective factors during this critical period of adoles-
cence, can significantly change the health trajectory into
adulthood [22].The rise of multimorbidity in the context of HIV
With the introduction of antiretroviral therapy (ART),
HIV can be considered a chronic disease [27]. In countries
with a high burden of HIV undergoing rapid urbanization
and epidemiological transition, HIV/NCD multimorbidity
is becoming increasingly prevalent [25] as people are living
longer with HIV [23, 24]. HIV-infected individuals are at
increased risk of NCDs compared to HIV-uninfected per-
sons, due partly to HIV-infection [26, 27] and the complica-
tions of long-term anti-retroviral therapy [28–30]. A study
in the United States reported that HIV-infected adults had
a 1.5 fold increased risk of having a heart attack [31] and
were nearly 50% more likely to have received a diagnosis of
chronic obstructive pulmonary disease (COPD) compared
to demographically and behaviourally similar uninfected
controls [32]. Other NCDs more commonly reported in
HIV-infected compared to un-infected persons include car-
diovascular events [33], hypertension [34, 35], osteoporosis
[36], renal impairment [37], diabetes mellitus [38], and de-
pression and neurocognitive disorders [39].
In high HIV-burden settings, multimorbidity is occur-
ring at younger ages with younger persons at a higher
level of risk for heart-related conditions attributed to
HIV infection [27]. HIV-infected adolescents, particu-
larly those with increased HIV viral load, have been re-
ported to have increased levels of cholesterol and
triglycerides [40] and increased biomarkers of vascular
dysfunction than HIV-exposed, uninfected adolescents
[41]. This is concerning for LMICs where there is a
younger age distribution of HIV-infected populations
[27]. In a review by Lowenthal et al., the authors found
that in sub-Saharan Africa, one of the striking features
of HIV infection in adolescence is the high prevalence of
chronic complications like chronic lung disease, cardiac
disease, growth failure, neurocognitive disease, skin,
renal and bone diseases [42].
This trend, and the fact that many unhealthy behav-
ioural patterns develop in adolescence, make integrated
prevention efforts necessary, and highlight the import-
ance of a focus on HIV-infected adolescents and youth
for multimorbidity prevention.
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South Africa
South Africa has the largest HIV epidemic worldwide
and the largest ART programme in the world. In 2016,
an estimated seven million people were living with HIV
in South Africa, with four million of those receiving
ART [43]. This epidemic persists in the context of epi-
demiological transition characterised by a quadruple
burden of communicable, non-communicable, perinatal
and maternal, and injury-related disorders [44]. Of the
1.6 million adolescents (aged 10–19 years) living with
HIV globally in 2018, 310,000 (19%) are in South Africa
[45]. These adolescents are growing up in an era of epi-
demiological transition, characterised by increasing bur-
den of NCDs driven by the unhealthy environments
within which they live, necessitating interventions to en-
hance protective environmental factors and minimize
risk behaviours [46].The opportunity for NCD prevention in adolescents with
a chronic disease (HIV)
Whilst young people generally do not access health care
services regularly, living with a chronic condition like
HIV which requires regular interaction with the health
care system [47] represents an opportunity for early
identification of NCD risk and intervention to reduce
the risk of NCD.
In South Arica, HIV patients in the public sector
are primarily seen and treated in HIV clinics. They
are routinely monitored via physical examination,
point of care and laboratory assessments as part of
routine clinical management for HIV. This includes
general health screening, patient history and biomed-
ical assessments which can also be used for other
chronic disease screening. There has been a gradual
move away from vertical services within HIV care, to-
wards more integrated care that includes NCD
screening and management in low- and middle-
income countries which face a dual burden of HIV
and NCDs. An integrated approach which harnesses
the successful programmatic approach of the HIV
treatment program is recommended to scale up ser-
vices for NCDs [48]. In South Africa, the National
Health Department introduced the Integrated Chronic
Disease Management (ICDM) model into primary
health care facilities in 2011 in order to bridge frag-
mented chronic disease care within the public health
care system and improve chronic disease health out-
comes [49, 50]. However, to date, these efforts have
focused on adults. This is despite a recognition of an
increasing burden of NCDs among people living with
HIV occurring at increasingly earlier ages [25, 27, 51],
and the importance of the adolescent and early youthperiod for development of NCD risk factors that in-
crease the risk of NCDs [13, 14].
Although systematic NCD screening is not formally
integrated within adolescent primary care HIV services,
general health screening and laboratory tests are done to
identify biomedical risk factors. However, it is unclear
the extent to which these preventive activities are con-
ducted. We therefore set out to investigate the extent to
which NCD comorbidity (prevention, screening and
management) is incorporated within existing adolescent
HIV primary healthcare services in Cape Town, South
Africa.
Methods
Setting
Cape Town- demographics and epidemiology
The study was conducted in Cape Town, the second
most populous city in South Africa with an estimated
population of 3.8 million people [52]. In 2016, adoles-
cents aged 10–19 years comprised 16.1% of the popula-
tion in the Western Cape province, within which Cape
Town is located [53].
Data for this study was collected from public primary
health care facilities across Cape Town: Khayelitsha,
Gugulethu, Langa, Brooklyn, Michell’s Plain, Kraaifon-
tein and Delft. These peri-urban neighbourhoods, lo-
cated on the outskirts of Cape Town are comprised of a
mix of formal and informal dwellings (with 20.5% of the
population residing in informal dwellings [54]), are char-
acterised by high unemployment levels (30%), with ap-
proximately 63% of households in the Khayelitsha/
Mitchells Plain district falling within the low income
bracket (earning < 280 USD per month) [55].
Non-communicable diseases and HIV are ranked
amongst the top causes of premature deaths in the City
of Cape Town [54], with the top five causes of death in
the Western Cape in 2016 ranked as diabetes mellitus,
HIV, ischaemic heart diseases, cerebrovascular diseases
and tuberculosis [56]. Antenatal HIV prevalence in Cape
Town city was estimated at 21.6% in 2015 [57], and as
high as 34.3% in Khayelitsha in 2012 [58].
Health system and HIV/NCD healthcare delivery
The City of Cape Town Metro Health district has eight
legislated sub-districts. Primary health care services are
delivered through four sub-structures (comprised of two
sub-districts in each sub-structure): Khayelitsha/Eastern,
Mitchell’s Plain/ Klipfontein, Western/Southern and
Northern Tygerberg sub-districts [54]. ART care is deliv-
ered through government clinics and is free to all pa-
tients, with patients with well-controlled disease
managed in ART “clubs”, which are either facility- or
community-based, and provide health screening, more
streamlined access to repeat prescriptions, health
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There were 5723 children under 15 years receiving ART
in the public health system in Cape Town in November
2016 (personal communication with Director of HIV
Treatment Programme: Provincial Government of the
Western Cape).
NCD screening, prevention and care is provided at the
primary care level as an entry point, with routine clinical
management of NCDs in primary care outpatient clinics.
Within these clinics, management of NCD patients with
well-controlled disease is primarily through chronic dis-
ease “clubs” in a similar manner to patients on ART.
Study design and sampling
We conducted a descriptive retrospective study from
November 2018 to March 2019, reviewing clinic folders
of adolescents and youth enrolled in HIV care across
Cape Town.
HIV clinic selection
The total number of children under 15 years receiving
HIV care in all clinics across all four legislated sub-
structures, was extracted from an internal reportFig. 1 Study population and sampling methodology across sub-districtsprovided by the Western Cape Department of Health.
As there were no routinely collected data for adoles-
cents, we utilised data for children under 15 years as a
proxy for adolescence and to identify healthcare facilities
with the largest number of adolescent and youth popula-
tions in care. Clinics with the highest number of chil-
dren under 15 registered as of November 2016 were
selected and a request for access to these submitted to
the Western Cape Department of Health. Approval was
received for nine clinics with the busiest 1–3 clinics se-
lected from each sub-structure.
Folder selection within each clinic
At each clinic selected, a de-identified population
master list of all adolescents and youth aged 10–24
years receiving ART was generated by visiting each
facility and compiling a sampling frame of 10–24 year
old patients with the assistance of data clerks at each
facility. We aimed to sample 10% of adolescents on
ART from each sub-structure (n = 463 overall) with
the required sample size at each clinic in each sub-
structure calculated proportional to the denominator
of the total adolescent patient population (Fig. 1).
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folders from the sampling frame master list, with the
first folder selected from the population list at ran-
dom, and every nth folder sampled thereafter, where
the sampling interval n was determined by the num-
ber of adolescents in the clinic population divided by
the number of adolescents needed for the sample. In
the event the nth folder was not found, the next
folder in the list was selected and the systematic sam-
pling continued until 10% of folders of adolescents in
each sub-structure were reviewed. Data collection was
conducted between November 2018–March 2019.Data extracted from folders
Health care visits in the preceding 12 months were
reviewed in each folder. In patients that had another
chronic disease diagnosis recorded, all episodes recorded
in the folder, irrespective of date, were extracted.Table 1 Demographic and HIV-related characteristics of 491 particip
November 2018–March 2019
Characteristic
Demographics Age at folder review (years)
Male
HIV-related
HIV management Age at ART initiation (years)
Duration on ART (years)
CD4 count (cells/mm3)
Viral suppression (< 20 copies/ml)
Current ART regimenc First line: ABC 3TC EFV
TDF FTC EFV
Second line: ABC 3TC LPV/r
AZT 3TC LPV/r
Other regimens
HIV opportunistic infections
Herpes zoster (shingles)
Pruritic papular eruption
Oral thrush
Oral candida
Oral hairy leucoplakia
Oesophageal candidiasis
Pneumocystis jirovecii pneumonia
HIV Encephalopathy
Cytomegalovirus disease
ART-related conditionsd
AZT-neutropenia
D4T-lipodystrophy, lipoatrophy
aDenominator = 491, unless otherwise indicated in this column; bPercentages may n
lamivudine, EFV efavirenz, TDF tenofovir, FTC emtricitabine, LPV/r lopinavir/ritonavir;Data relating to HIV including treatment and oppor-
tunistic infections, NCD diagnosis and treatment (dia-
betes, hypertension, asthma, mood disorders, epilepsy),
NCD risk (overweight/obesity, raised blood pressure,
substance abuse, and smoking), and general medical his-
tory including family history, were extracted from par-
ticipant folders (See Table 1). Any recorded health
promotion interventions related to HIV, sexual health or
NCD risk were also extracted. A more detailed descrip-
tion of data collected and definitions used is included in
an additional file [see Additional file 1].
Analysis
Descriptive statistics (median (IQR) and frequencies and
percentages) were used to describe continuous and cat-
egorical variables, respectively. All analyses were con-
ducted using STATA v14.0 (StataCorp. 2015. Stata
Statistical Software: Release 14. College Station, TX: Sta-
taCorp LP).ants aged 10–24 years receiving ART across Cape Town,
N = 491a Median (IQR) or n (%)b
20 (14–23)
127 (26%)
473 (96%) 18 (6–21)
471 (96%) 3.1 (1.1–8.9)
395 (80%) 489 (355 --690)
369 (75%) 256 (69%)
84 (17%)
298 (61%)
39 (8%)
29 (6%)
41 (8%)
28 (6%)
11 (39%)
8 (29%)
2 (7%)
2 (7%)
1 (3.6%)
1 (3.6%)
1 (3.6%)
1 (3.6%)
1 (3.6%)
8 (2%)
1 (13%)
7 (87%)
ot total 100 due to rounding; cCurrent ART regimens: ABC Abacavir, 3TC
dART-related conditions: AZT zidovudine, D4T stavudine
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A total of 491 folders were reviewed from a master list
of 4631 patients. The median participant age was 20
years (Interquartile range (IQR): 14–23 years); 74% were
female; median age at ART initiation was 18 years (IQR:
6–21 years) and the median duration on ART was 3
years (IQR: 1.1–8.9 years) (Table 1).
HIV management
The majority of patients were virally suppressed (69%)
(median CD4 count 489 cells/mm3 (IQR (355—690
cells/mm3)) and on first line ART regimens (78%),
(fixed-dose tenofovir-based (61%); abacavir- lamivudine
based regimens (17%)) as shown in Table 1.
HIV opportunistic infections
Seven percent (36/491) had a documented HIV oppor-
tunistic infection or an ART-related condition. Of those,
the most prevalent conditions were herpes zoster/ shin-
gles (39%), followed by pruritic papular eruption (PPE)
(29%), and oral thrush (7%) or oral candida (7%). The re-
ported cases of opportunistic infections were docu-
mented to have received appropriate treatment
(antibiotics, antivirals or antifungals). In addition, 14% of
non-ARV medications prescribed in the previous 12
months consisted of cotrimoxazole prophylaxis to pre-
vent opportunistic infections.
NCD comorbidity
Fifty-five percent (n = 268) of folders reviewed had docu-
mented information on comorbidities, of which 11%
were NCD comorbidities. Of these, the most prevalent
NCDs documented were chronic respiratory diseases
(asthma, bronchitis, COPD (60%)) and mental health
disorders (depression, anxiety or other mental health
conditions (37%)) (Table 1). Despite this, only one par-
ticipant was documented as receiving treatment for
asthma. Other documented NCD treatment received in
the previous 12 months were for high blood pressure,
psychosis and high cholesterol/ triglycerides.
NCD risk
In terms of NCD risk factors documented, 4% were
current smokers or had a history of smoking, and 3%
used alcohol, drugs or other substances. Only 62% of
folders reviewed had documented anthropometric data
(height and weight). Of these, 48% were overweight or
obese (26 and 22% respectively) and 10% were under-
weight. Fifty-nine percent of folders reviewed had a doc-
umented blood pressure. Of these, the majority (73%)
were normal (< 130/85 mmHg), 14% had elevated blood
pressure, and 12% showed signs of mild hypertension
(SBP 140-159 mmHg or DBP 90- 99 mmHg). There werethree cases (1%) with moderate hypertension docu-
mented (SBP 160–179 mmHg or DBP 100–109 mmHg).
General medical information
Family history was documented in 6% of the folders
reviewed. Of these, the most common condition docu-
mented was tuberculosis (69%), followed by diabetes
(14%), high blood pressure (7%) and alcoholism (7%).
Other non-infectious conditions were documented in
11% of the folders reviewed. These conditions ranged
from current/ previous pregnancy (60%), experiences of
trauma due to injury or violence (11%) and epilepsy,
learning difficulties (10%) and failure to thrive (10%).
There were isolated cases reported of conditions such as
peripheral neuropathy, hearing loss, impetigo, severe
dermatitis and lymphadenopathy.
Non-HIV infectious diseases
Thirty-eight percent had non-HIV infectious diseases on
record. Tuberculosis was the most documented infectious
disease. Of the 38% with an infectious comorbidity re-
ported, 62% had been diagnosed with tuberculosis in the
past, 22% had been diagnosed with a sexually transmitted
infection and 6% had a history of scabies. Five percent had
been diagnosed with pneumonia as an infant or continued
to experience severe recurrent bacterial/ viral pneumonia
(not Pneumocystis jiroveci pneumonia-PJP). Herpes sim-
plex virus and meningitis were reported in 3% of the
folders.
Other non-ARV medications prescribed in the last 12
months (27%) were TB prophylaxis (22%), antibiotics
(33%), STI treatment (17%), steroids (12%), antiviral
medication (2%) and contraceptives (4%).
Health promotion interventions
Twenty-six percent of participants had a documented
health promoting intervention, ranging from HIV- and
NCD- to sexual and reproductive health-related inter-
ventions. Seven percent received disclosure counselling
to facilitate full disclosure of their HIV status and 9%
underwent adherence counselling (Table 2). For NCD-
related health promotion, 13% received alcohol or sub-
stance abuse counselling; 10% received mental health
counselling, 9% were advised on healthy weight or diet
and 9% were counselled about smoking tobacco. One
singular case was documented of a diabetes screening
intervention. Eleven percent underwent family planning
or basic antenatal care counselling each, while 5% were
referred for a pap smear or breast examination, Medical
male circumcision and safe sex counselling were docu-
mented in 2% of the folders. Other health promotion in-
terventions documented were hygiene counselling (3%)
and physiotherapy/occupational therapy (2%).
Table 2 NCD comorbidity, general medical information and health promotion interventions documented in folders of 491
participants aged 10–24 years receiving ART across Cape Town, November 2018–March 2019
Characteristic N = 491a n (%)b
Comorbidity Information 268 (55%)
NCD diagnosis 30 (11%)
Depression, anxiety or other mental health condition 11 (37%)
Bronchitis, lung disease, asthma or other chronic respiratory diseasec 18 (60%)
Cancer 1 (3%)
NCD treatment 4 (1%)
Asthma treatment 1 (25%)
High Blood Pressure treatment 1 (25%)
Antipsychotic medication 1 (25%)
High cholesterol/ triglycerides 1 (25%)
NCD risk factors 305 (62%)
Smoking: current smoker or history of smoking 11 (4%)
Alcohol, drugs or other substance abuse 9 (3%)
Body Mass Index (BMI) kg/m2 305 (62%)
Underweight: BMI < 18.5 30 (10%)
Normal weight: BMI 18.5–25 129 (42%)
Overweight: BMI 25–30 80 (26%)
Obese: BMI ≥30 66 (22%)
Blood Pressure mmHgd 289 (59%)
Normal: SBP < 130 and DBP < 85 210 (73%)
High normal: SBP 130–139/DBP 85–89 41 (14%)
Mild hypertension: SBP 140–159/DBP 90–99 35 (12%)
Moderate hypertension: SBP 160–179/ DBP 100–109 3 (1%)
General medical information: Contraception 18 (4%)
Family History 29 (6%)
Tuberculosis 20 (69%)
Diabetes 4 (14%)
High blood pressure 2 (7%)
Alcoholism 2 (7%)
Cancer 1 (3%)
Other conditions 52 (11%)
Pregnancy 31 (60%)
Trauma- injury and violence 6 (11%)
Epilepsy 5 (10%)
Learning Difficulties 5 (10%)
Failure to Thrive 5 (10%)
Non-HIV infectious diseases 185 (38%)
Non-HIV infectious disease diagnosis Tuberculosis 114 (62%)
Sexually Transmitted Infections 40 (22%)
Scabies 12 (6%)
Pneumonia 9 (5%)
Herpes Simplex Virus 5 (3%)
Meningitis 5 (3%)
Kamkuemah et al. BMC Public Health          (2020) 20:821 Page 7 of 11
Table 2 NCD comorbidity, general medical information and health promotion interventions documented in folders of 491
participants aged 10–24 years receiving ART across Cape Town, November 2018–March 2019 (Continued)
Characteristic N = 491a n (%)b
Non-ARV medications prescribed in Iast 12months 135 (27%)
TB prophylaxis 30 (22%)
Cotrimoxazole 19 (14%)
STI treatment 23 (17%)
Antibiotics 44 (33%)
Steroids 16 (12%)
Antivirals 3 (2%)
Health Promotion 93 (19%)e
HIV-related Disclosure counselling 9 (7%)
Adherence counselling 11 (9%)
NCD-related Alcohol counselling 14 (11%)
Mental health counselling 13 (10%)
Healthy diet or weight counselling 12 (9%)
Smoking counselling 11 (9%)
Substance abuse counselling 2 (2%)
Diabetes screening 1 (1%)
Sexual and Reproductive Health Family planning 14 (11%)
Basic antenatal counselling 14 (11%)
Postnatal care & Infant feeding counselling 10 (8%)
Pap smear & Breast examination 6 (5%)
Safe sex counselling 2 (2%)
Medical male circumcision 2 (2%)
Other Health Promotion Hygiene counselling 4 (3%)
Physiotherapy/Occupational Therapy 2 (2%)
aDenominator = 491, unless otherwise indicated in this column
bPercentages may not total 100 due to rounding
cIncludes asthma, Chronic Obstructive Pulmonary Disease, and other respiratory conditions
dSBP = Systolic Blood Pressure and DBP = Diastolic Blood Pressure
eTotal interventions > 93 as some individuals had more than one form of health promotion documented
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This study describes documentation of NCD and
NCD risk screening and health promotion in HIV-
infected adolescents and youth receiving ART in an
urban setting in South Africa. We found that only
55% of the folders reviewed had any information on
other comorbidities and 62% had risk factor informa-
tion. Of these, 11% were NCD comorbidities ranging
from mental health conditions to chronic respiratory
diseases. A key finding of this study is the paucity of
data on NCD and NCD risk captured as part of clin-
ical care of adolescents with HIV. Poor documenta-
tion and screening of NCD risk-factors for the
majority of participants in our study demonstrates a
missed opportunity for detecting comorbidity and
NCD risk in primary health care and for early inter-
vention in AYLHIV who represent an important
population and are less inclined to seek regular orpreventive care. Early identification and intervention
to modify behaviour would prevent a costly future
epidemic of NCDs and avert morbidity and mortality
due to NCDs [10].
Data paucity notwithstanding, our results highlight
evidence of co-existing NCD multimorbidity and NCD
risk factors (overweight and obesity, elevated BP and
smoking, alcohol and substance use) in AYLHIV. A
similar study in the US conducted a retrospective chart
review in HIV-positive children and adolescents aged 2–
25 years and found an 18% prevalence of high blood
pressure [64]. In that study, there were significant associ-
ations with other medical comorbidities and risk factors
such as tobacco exposure and male gender. The authors
highlighted that the life-long cardiovascular risks associ-
ated with HIV infection and its management call for
closer monitoring and possibly treatment of elevated BP
in this population [64]. Another study conducted in
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as our study demonstrated that 19% of HIV-infected pa-
tients on ART were on treatment for another chronic
disease (diabetes, tuberculosis or hypertension), with 77
and 17% of them receiving anti-hypertensive and dia-
betic treatment respectively [25].
Previous studies in healthy young people have shown
prevalence rates of overweight and obesity of 23 to 7%
respectively [65] and hypertension/elevated blood pres-
sure rates of 6.7% in respondents in the 15–24-year age
group [59]. Whilst the prevalence of these NCD risks
cannot be estimated from our study due to the limited
documentation, these previous surveys in South Africa
demonstrate risk factors for NCDs in adolescents in the
general population. Given the data from adults with HIV
in South Africa, there is an indication that the preva-
lence of NCD risk in adolescents with HIV is potentially
higher than their healthy counterparts [25, 66], strength-
ening the argument for targeted NCD prevention efforts
in this population group to prevent multimorbidity.
Given that some NCDs (such as mental disorders) and
many NCD risk behaviours such as substance abuse also
influence HIV control, our finding that 69% of partici-
pants were virally suppressed further emphasises the
need for strengthened integrated health systems.
In this study, we noted that only 19% had a docu-
mented health promoting intervention, ranging from al-
cohol or substance abuse (13%) to healthy weight or diet
(13%) and mental health counselling (10%). Family his-
tory of an NCD has been shown to be a significant risk
factor for NCD in South Africa [59] and so should form
an important component of NCD risk assessment. In
this study, only 6% had a documented family history re-
corded. Other upstream determinants of NCD risk such
as the social environment were not noted.
As has been demonstrated in adult patients, chronic
disease care requires a comprehensive, holistic approach
that integrates treatment and prevention of multiple
conditions [60, 61]. Such an approach, integrating NCD
primary prevention with HIV care, will be an important
component of strategies to reduce multimorbidity and
the future burden of NCDs in high HIV-burden settings.
In South Africa, strategies like the ICDM and Chronic
Disease Clubs, responding to the observed epidemio-
logical transition and rise of HIV/NCD multimorbidity,
are aimed at integrating chronic (infectious and non-
communicable) disease programs using established and
existent frameworks to expand access to primary care
that includes services for both HIV and NCDs [48].
Pilot projects are underway in selected primary health
care facilities to investigate the most effective models of
integrated care [62]. Early findings demonstrate provider
and patient satisfaction with several dimensions of the
model [63]. But leveraging elements of HIV programmesfor NCDs, like hypertension management was noted to
be inadequate, in part due to malfunctioning equipment
and drug stock-outs [62]. To date, these models have fo-
cused on the general adult population, with no inte-
grated clinics for adolescents planned largely due to a
paucity of data on NCD co-morbidities and NCD risk in
adolescents with HIV. These efforts have largely ignored
adolescents and youth with a focus solely on HIV-
specific outcomes and neglecting an opportunity to
intervene holistically in a target at-risk population regu-
larly accessing care.
Our results demonstrate a missed opportunity to im-
prove health, and prevent multimorbidity, in this im-
portant population group with unique health needs.
A key limitation of our study was the retrospective na-
ture of data collection. We were unable to estimate the
prevalence of NCD or NCD risk in this population due
to the possibility of screening bias and underreporting.
Furthermore, the health promotion activities assessed
are those which were documented in patient folders
which may under-estimate actual health promotion in-
terventions delivered. Given the limitations of the study
design, we instead set out to describe the extent to
which NCD comorbidity screening, prevention and man-
agement is incorporated within existing adolescent HIV
primary healthcare services.
Another limitation is that we were unable to explore
determinants of NCD comorbidity due to the low num-
ber of NCD diagnoses recorded. Such information could
be used to inform targeted and cost-effective approaches
to NCD screening.
However, the NCD data paucity noted represents an
important finding for the health system as it demon-
strates limited consideration of NCD prevention in HIV
care and highlights a missed opportunity for NCD pre-
vention in a patient group regularly accessing health
care. This study was therefore an important first step to
inform future research on the epidemiology of NCD and
NCD risk factors in AYLHIV.
Conclusion
Our data demonstrates the existence of NCD risk factors
in adolescents and youth, though poorly documented at
the primary care level. This highlights a missed oppor-
tunity in multimorbidity prevention through the
provision of NCD screening and prevention services to
AYLHIV. Further research is needed to better ascertain
NCD prevalence and NCD risk epidemiology in AYL-
HIV. Whilst our study focused on HIV, these findings
are relevant for adolescents with any chronic condition
who are interacting with health services regularly.
Addressing this missed opportunity would require an
integrated health system. Further research is needed to
inform the most effective models of care for HIV
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effectively respond to communicable and NCD preven-
tion and control. In addition, intersectoral collaboration
with non-health sectors incorporating upstream environ-
mental, socio-economic and cultural determinants of
NCD risk into prevention efforts are vital to multimor-
bidity prevention efforts, particularly in the context of
rapid urbanization. An early identification and preven-
tion approach to NCD control in HIV-infected adoles-
cents and young adults is vital to turn the tide on the
NCD and multimorbidity epidemic and avert the eco-
nomic implications of NCDs to individuals, families and
societies, whilst simultaneously improving HIV out-
comes and reducing the risk of NCD in this key popula-
tion group.
Supplementary information
Supplementary information accompanies this paper at https://doi.org/10.
1186/s12889-020-08921-0.
Additional file 1. contains detailed information on all data collected as
part of the folder review process and definitions of variables used in the
study.
Abbreviations
ART: Antiretroviral therapy; ABC: Abacavir; AZT: Zidovudine; 3TC: Lamivudine;
D4T: Stavudine; EFV: Efavirenz; FTC: Emtricitabine; LPV/r: Lopinavir/ritonavir;
TDF: Tenofovir; BMI: Body mass index; COPD: Chronic obstructive pulmonary
disease; DBP: Diastolic Blood Pressure; SBP: Systolic Blood Pressure;
NCD: Non-communicable disease; LMIC: Low- and middle-income countries
Acknowledgements
The authors appreciate the assistance from the City of Cape Town and
Western Cape Departments of Health who made access to the facilities and
data possible. We would like to thank respective district managers, facility
managers, nurses and data quality officers within the provincial and local
health departments for their help during data collection.
Authors’ contributions
MK conducted data collection, led data analysis and interpretation, and
wrote the first draft of the manuscript; TO conceptualized the study,
contributed to data interpretation, and manuscript preparation; BG
conducted data collection, contributed to data interpretation, and
manuscript preparation. All authors read and approved the final manuscript.
Funding
This work was supported by the Bristol-Myers Squibb Foundation (grant
number 430960). MK was supported by the South African National Research
Foundation (NRF) under joint funding with the German Academic Exchange
Service (DAAD) for her PhD. The funding bodies had no role in the design of
the study, data collection, analysis, interpretation of data or in writing the
manuscript.
Availability of data and materials
The data that support the findings of this study are not publicly available
due to the sensitive nature of information that could compromise minor
research participants’ privacy/consent but are available from the
corresponding author MK on reasonable request.
Ethics approval and consent to participate
This study was approved by the University of Cape Town, Faculty of Health
Sciences Human Research Ethics committee (HREC Ref no: 520/2017) and
permission to conduct the study was obtained from the provincial and local
government health departments.Consent for publication
Not applicable.
Competing interests
The authors declare that they have no competing interests.
Author details
1Research Initiative for Cities Health and Equity, Division of Public Health
Medicine, School of Public Health and Family Medicine, University of Cape
Town, Cape Town 7925, South Africa. 2Medical Research Council
Epidemiology Unit, University of Cambridge, Cambridge CB2 0QQ, UK.
Received: 25 November 2019 Accepted: 14 May 2020
References
1. Benziger CP, Roth GA, Moran AE. The global burden of disease study and
the preventable burden of NCD. Glob Heart. 2016;11(4):393–7.
2. World Health Organization. Noncommunicable diseases; 2014. http://www.
who.int/mediacentre/factsheets/fs355/en/. Accessed 03 October 2019.
3. World Health Organization. Global status report on noncommunicable
diseases 2014. Geneva: World Health Organisation; 2014. http://apps.who.
int/iris/bitstream/10665/148114/1/9789241564854_eng.pdf?ua=1. Accessed
03 Oct 2019.
4. Abubakar I, Tillmann T, Banerjee A. Global, regional, and national age-sex
specific all-cause and cause-specific mortality for 240 causes of death, 1990-
2013: a systematic analysis for the global burden of disease study 2013.
Lancet. 2015;385(9963):117–71.
5. Forouzanfar MH, Afshin A, Alexander LT, Anderson HR, Bhutta ZA, Biryukov
S, et al. Global, regional, and national comparative risk assessment of 84
behavioural, environmental and occupational, and metabolic risks or
clusters of risks, 1990–2016: a systematic analysis for the global burden of
disease study 2016. Lancet. 2016;388(10053):1659–724.
6. Santosa A, Wall S, Fottrell E, Högberg U, Byass P. The development and
experience of epidemiological transition theory over four decades: a
systematic review. Glob Health Action. 2014;7:1.
7. Oni T, Unwin N. Why the communicable/non-communicable disease
dichotomy is problematic for public health control strategies: implications
of multimorbidity for health systems in an era of health transition. Int
Health. 2015;7(6):390 ihv040.
8. Daniels ME, Donilon TE, Bollyky TJ. The emerging global health crisis:
noncommunicable diseases in low-and middle-income countries. In:
Council on Foreign Relations independent task force report, vol. 72; 2014.
9. Atun R, Davies JI, Gale EA, Bärnighausen T, Beran D, Kengne AP, et al.
Diabetes in sub-Saharan Africa: from clinical care to health policy. Lancet
Diabetes Endocrinol. 2017;5(8):622–67.
10. World Bank. The growing danger of non-communicable diseases: acting
now to reverse course. Conference paper: 2011; 2011.
11. Darnton-Hill I, Nishida C, James WP. A life course approach to diet, nutrition
and the prevention of chronic diseases. Public Health Nutr. 2004;7(1a):101–21.
12. World Health Organization. Health needs of adolescents: report of a WHO
expert committee. WHO Technical Report Series; 1977.
13. World Health Organization. The second decade: improving adolescent
health and development. Geneva: World Health Organization; 2001.
14. Steinberg L. Risk taking in adolescence: what changes, and why? Ann N Y
Acad Sci. 2004;1021(1):51–8.
15. Patton GC, McMorris BJ, Toumbourou JW, Hemphill SA, Donath S, Catalano
RF. Puberty and the onset of substance use and abuse. Pediatrics. 2004;
114(3):e300–6.
16. Steinberg L, Morris AS. Adolescent development. J Cogn Educ Psychol.
2001;2(1):55–87.
17. Sheehan P, Sweeny K, Rasmussen B, Wils A, Friedman HS, Mahon J, et al. Building
the foundations for sustainable development: a case for global investment in the
capabilities of adolescents. Lancet. 2017;390(10104):1792–806.
18. Hervish A, Clifton D. The status report on adolescents and young people in
sub-Saharan Africa: opportunities and challenges. Washington, DC:
Population Reference Bureau; 2012.
19. Currie C, Gabhainn SN, Godeau E, Committee IHNC. The health behaviour in
school-aged children: WHO collaborative cross-national (HBSC) study:
origins, concept, history and development 1982–2008. Int J Public Health.
2009;54(2):131–9.
Kamkuemah et al. BMC Public Health          (2020) 20:821 Page 11 of 1120. Arrazola RA, Ahluwalia IB, Pun E, de Quevedo IG, Babb S, Armour BS.
Current tobacco smoking and desire to quit smoking among students aged
13–15 years—global youth tobacco survey, 61 countries, 2012–2015. MMWR
Morb Mortal Wkly Rep. 2017;66(20):533.
21. World Health Organisation. Global status report on alcohol and health,
2014. Geneva: World Health Organization; 2014. https://apps.who.int/iris/
bitstream/handle/10665/112736/9789240692763_eng.pdf?sequence=1.
Accessed 24 Sept 2019.
22. Azzopardi P. Adolescent health comes of age. Lancet. 2012;379(9826):1583–4.
23. Nakagawa F, May M, Phillips A. Life expectancy living with HIV: recent
estimates and future implications. Curr Opin Infect Dis. 2013;26(1):17–25.
24. Wandeler G, Johnson LF, Egger M. Trends in life expectancy of HIV-positive
adults on ART across the globe: comparisons with general population. Curr
Opin HIV AIDS. 2016;11(5):492.
25. Oni T, Youngblood E, Boulle A, McGrath N, Wilkinson RJ, Levitt NS. Patterns
of HIV, TB, and non-communicable disease multi-morbidity in peri-urban
South Africa- a cross sectional study. BMC Infect Dis. 2015;15:20.
26. Deeks SG. HIV infection, inflammation, immunosenescence, and aging.
Annu Rev Med. 2011;62:141.
27. Deeks SG, Lewin SR, Havlir DV. The end of AIDS: HIV infection as a chronic
disease. Lancet. 2013;382(9903):1525–33.
28. Dillon DG, Gurdasani D, Riha J, Ekoru K, Asiki G, Mayanja BN, et al.
Association of HIV and ART with cardiometabolic traits in sub-Saharan
Africa: a systematic review and meta-analysis. Int J Epidemiol. 2013;42(6):
1754–71.
29. Thienemann F, Sliwa K, Rockstroh JK. HIV and the heart: the impact of
antiretroviral therapy: a global perspective. Eur Heart J. 2013;34(46):3538–46.
30. Madeddu G, Fois A, Calia G, Babudieri S, Soddu V, Becciu F, et al. Chronic
obstructive pulmonary disease: an emerging comorbidity in HIV-infected
patients in the HAART era? Infection. 2013;41(2):347–53.
31. Freiberg MS, Chang C-CH, Kuller LH, Skanderson M, Lowy E, Kraemer KL,
et al. HIV infection and the risk of acute myocardial infarction. JAMA Intern
Med. 2013;173(8):614–22.
32. Crothers K, Butt AA, Gibert CL, Rodriguez-Barradas MC, Crystal S, Justice AC.
Increased COPD among HIV-positive compared to HIV-negative veterans.
Chest J. 2006;130(5):1326–33.
33. Triant VA, Lee H, Hadigan C, Grinspoon SK. Increased acute myocardial
infarction rates and cardiovascular risk factors among patients with human
immunodeficiency virus disease. J Clin Endocrinol Metab. 2007;92(7):2506–12.
34. Achwoka D, Waruru A, Chen T-H, Masamaro K, Ngugi E, Kimani M, et al.
Noncommunicable disease burden among HIV patients in care: a national
retrospective longitudinal analysis of HIV-treatment outcomes in Kenya,
2003-2013. BMC Public Health. 2019;19(1):372.
35. Kwarisiima D, Balzer L, Heller D, Kotwani P, Chamie G, Clark T, et al. Population-
based assessment of hypertension epidemiology and risk factors among HIV-
positive and general populations in rural Uganda. PLoS One. 2016;11:5.
36. McComsey GA, Tebas P, Shane E, Yin MT, Overton ET, Huang JS, et al. Bone
disease in HIV infection: a practical review and recommendations for HIV
care providers. Clin Infect Dis. 2010;51(8):937–46.
37. Reid A, Stöhr W, Walker AS, Williams IG, Kityo C, Hughes P, et al. Severe renal
dysfunction and risk factors associated with renal impairment in HIV-infected
adults in Africa initiating antiretroviral therapy. Clin Infect Dis. 2008;46(8):1271–81.
38. Butt AA, McGinnis K, Rodriguez-Barradas MC, Crystal S, Simberkoff M, Goetz
MB, et al. HIV infection and the risk of diabetes mellitus. AIDS (London,
England). 2009;23(10):1227.
39. Ammassari A, Antinori A, Aloisi MS, Trotta MP, Murri R, Bartoli L, et al.
Depressive symptoms, neurocognitive impairment, and adherence to highly
active antiretroviral therapy among HIV-infected persons. Psychosomatics.
2004;45(5):394–402.
40. Miller T, Wang J, Jacobson D, Takemoto J, Sharma T, Geffner M, et al.
Mitochondrial function and metabolic abnormalities in children with
perinatally-aquired HIV infection in the pediatric HIV/AIDS cohort study
(PHACS). J Int AIDS Soc. 2012;15:69–70 Int AIDS Society Avenue De France
23, Geneva, 1202, Switzerland; 2012: Oct 1.
41. Miller TL, Borkowsky W, DiMeglio LA, Dooley L, Geffner ME, Hazra R, et al.
Metabolic abnormalities and viral replication are associated with biomarkers
of vascular dysfunction in HIV-infected children. HIV Med. 2012;13(5):264–75.
42. Lowenthal ED, Bakeera-Kitaka S, Marukutira T, Chapman J, Goldrath K,
Ferrand RA. Perinatally acquired HIV infection in adolescents from sub-
Saharan Africa: a review of emerging challenges. Lancet Infect Dis. 2014;
14(7):627–39.43. Joint United Nations Programme on HIV/AIDS, Joint United Nations
Programme on HIV/AIDS. UNAIDS, data 2017. Geneva: UNAIDS; 2017.
44. Mayosi BM, Flisher AJ, Lalloo UG, Sitas F, Tollman SM, Bradshaw D. The
burden of non-communicable diseases in South Africa. Lancet. 2009;
374(9693):934–47.
45. UNICEF. Key HIV epidemiology indicators for children and adolescents aged 0–
19, 2000–2018. https://data.unicef.org/wp-content/uploads/2019/07/HIV_
Epidemiology_Children_Adolescents_2019.xlsx. Accessed 24 September 2019.
46. Baker R, Taylor E, Essafi S, Jarvis JD, Odok C. Engaging young people in the
prevention of noncommunicable diseases. Bull World Health Organ. 2016;
94(7):484.
47. Hazra R, Siberry GK, Mofenson LM. Growing up with HIV: children,
adolescents, and young adults with perinatally acquired HIV infection*.
Annu Rev Med. 2010;61:169–85.
48. Joint United Nations Programme on HIV/AIDS. Chronic care of HIV and non-
communicable diseases: how to leverage the HIV experience; 2011.
49. Asmall S, Mahomed O. Integrated chronic disease management manual.
Pretoria: Department of Health; 2013.
50. Kawonga M, Fonn S, Blaauw D. Administrative integration of vertical HIV
monitoring and evaluation into health systems: a case study from South
Africa. Glob Health Action. 2013;6(1):19252.
51. Innes S, Patel K. Noncommunicable diseases in adolescents with perinatally
acquired HIV-1 infection in high-income and low-income settings. Curr
Opin HIV AIDS. 2018;13(3):187–95.
52. Statistics South Africa. Mid-year population estimates 2018. Report P0302
Pretoria: Statistics South Africa; 2018.
53. Western Cape Government Health Department. Annual performance plan
2016–2017Department of Health; 2016.
54. Cape Metro Health District. Cape Metro District health plan 2018/19–2020/
21. Cape Town: District Management Team; 2018.
55. Western Cape Government: 2016 Socio-economic Profile: City of Cape
Town. Department of Social Development. Cape Town; 2016. https://www.
westerncape.gov.za/assets/departments/treasury/Documents/Socio-
economic-profiles/2016/City-of-Cape-Town/city_of_cape_town_2016_socio-
economic_profile_sep-lg.pdf. Accessed 03 Oct 2019.
56. Statistics South Africa. Mortality and causes of death in South Africa, 2016:
findings from death notificationStatistics South Africa; 2018.
57. National Department of Health, editor. The 2015 National Antenatal Sentinel
HIV & Syphilis Survey, South Africa, National Department of health. Pretoria:
Edited by National Department of Health; 2017.
58. National Department of Health, editor. The 2012 National Antenatal Sentinel
HIV & Herpes Simplex Type-2 prevalence survey in South Africa. Pretoria:
Edited by National Department of Health; 2014.
59. Shisana O. The South African National Health and Nutrition Examination
Survey: SANHANES-1: HSRC press; 2013.
60. de Bruin SR, Versnel N, Lemmens LC, Molema CCM, Schellevis FG, Nijpels G,
et al. Comprehensive care programs for patients with multiple chronic
conditions: a systematic literature review. Health Policy. 2012;107(2–3):108–45.
61. Nuño R, Coleman K, Bengoa R, Sauto R. Integrated care for chronic conditions:
the contribution of the ICCC framework. Health Policy. 2012;105(1):55–64.
62. Ameh S, Klipstein-Grobusch K, Musenge E, Kahn K, Tollman S, Gomez-Olive
FX. Effectiveness of an integrated approach to HIV and hypertension Care in
Rural South Africa: controlled interrupted time-series analysis. J Acquir
Immune Defic Syndr. 2017;75(4):472–9.
63. Ameh S, Klipstein-Grobusch K, D’ambruoso L, Kahn K, Tollman SM, Gómez-
Olivé FX. Quality of integrated chronic disease care in rural South Africa:
user and provider perspectives. Health Policy Plan. 2017;32(2):257–66.
64. Chatterton-Kirchmeier S, Camacho-Gonzalez AF, McCracken CE, Chakraborty R,
Batisky DL: Increased prevalence of elevated blood pressures in HIV-infected
children, adolescents and young adults. Pediatr Infect Dis J. 2015;34(6):610–14.
65. Reddy S, James S, Sewpaul R, Sifunda S, Ellahebokus A, Kambaran NS,
Omardien RG: Umthente uhlaba usamila: the 3rd South African national
youth risk behaviour survey 2011. 2013.
66. Levitt NS, Steyn K, Dave J, Bradshaw D. Chronic noncommunicable diseases
and HIV-AIDS on a collision course: relevance for health care delivery,
particularly in low-resource settings—insights from South Africa. Am J Clin
Nutr. 2011;94(6):1690S–6S.
Publisher’s Note
Springer Nature remains neutral with regard to jurisdictional claims in
published maps and institutional affiliations.
